pharmacy-benefits managers

The new partners seek to close the information loop by including providers, payors, and patients in biomarker-guided cancer therapy decisions.

The technology vendor and the PBM will offer a bundled platform to help guide cancer patients to the most appropriate treatments.

According to Myriad, a similar deal is in the works with the pharmacy benefit management services provider for its GeneSight pharmacogenetic test.